PureTech Health PLC
LSE:PRTC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
PureTech Health PLC (PRTC) under the Base Case is GBX per share.
Compared with the current market price of 126 GBX, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What PureTech Health Does
PureTech Health is a biotechnology company that builds and develops new medicines for hard-to-treat diseases. It starts with scientific ideas around biology and turns them into drug programs, often by creating or backing separate portfolio companies to carry the work forward. Its value comes from discovering promising therapies, advancing them through research and clinical testing, and partnering or spinning them out when they reach the right stage.
- Headquarters
- United States of America US
- Employees
- 61
- IPO date
- Jun 19, 2015
Earnings Waterfall
PureTech Health PLC
What is the Intrinsic Value of one PRTC stock?
The intrinsic value for PureTech Health PLC (PRTC) under the Base Case is GBX.
Is PRTC stock undervalued or overvalued?
Compared with the current market price of 126 GBX, the stock appears .
